Tetrahydroberberine Suppresses Autophagy and Mitigates Doxorubicin‐Induced Ferroptosis in Hepatic Cells via cAMP ‐Epac1 Activation
Phytotherapy Research · 02.11.2026
DOI: 10.1002/ptr.70500 ↗Kurz gefasst
Fachartikel in der Zeitschrift Phytotherapy Research, online erschienen am 02.11.2026. Verfasst von Cheng Teng und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Zhejiang Cancer Hospital, Zhejiang, Hangzhou, China. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hangzhou Institute of Medicine, Chinese Academy of Sciences, the Zhejiang Provincial Medical and Health Science and Technology Program, the Zhejiang Cancer Hospital National Natural Science Foundation of Cultivation Fund Program.
Abstract (Originalsprache)
This study investigated the hepatoprotective mechanism of tetrahydroberberine (THB) against doxorubicin (DOX)‐induced liver injury. Using DOX‐induced drug‐induced liver injury (DILI) mouse models and AML12 hepatocytes, THB significantly reduced serum ALT/AST levels, alleviated hepatic pathological damage, and suppressed autophagic flux and ferroptosis. Mechanistically, THB activated the cAMP‐Epac1 axis by directly binding Epac1, stabilizing FTH1 and upregulating GPX4, thereby blocking the crosstalk between ferritinophagy and ferroptosis. Network pharmacology suggested the cAMP pathway, and experimental validation identified Epac1 as the functional target. These mechanisms were validated using ESI‐09, rapamycin, 3‐MA, CETSA, and molecular docking. This study is the first to elucidate THB's hepatoprotective mechanism via the cAMP‐Epac1/FTH1/GPX4 pathway, offering a natural product‐based strategy for chemotherapy‐associated liver injury.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Anesthesiology, Zhejiang Cancer Hospital, Zhejiang, Hangzhou, China.
- Laboratory of Anesthesia and Perioperative Medicine, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Zhejiang, Hangzhou, China.
- Department of Physiology, Naval Medical University, Shanghai, China.
ORCID-Profile: Mo Chen, Xiaoyan Zhu, Pengxiang Wang, Pingbo Xu
Förderung
- Hangzhou Institute of Medicine, Chinese Academy of Sciences
- the Zhejiang Provincial Medical and Health Science and Technology Program
- the Zhejiang Cancer Hospital National Natural Science Foundation of Cultivation Fund Program
Zitieren
APA
Teng, C., Chen, M., Zhao, Y., Hu, S., Kong, L., Huang, Y., Cai, S., Zhu, X., Wang, P., & Xu, P. (2026). Tetrahydroberberine Suppresses Autophagy and Mitigates Doxorubicin‐Induced Ferroptosis in Hepatic Cells via cAMP ‐Epac1 Activation. Phytotherapy Research. https://doi.org/10.1002/ptr.70500
Vancouver
Teng C, Chen M, Zhao Y, Hu S, Kong L, Huang Y, et al. Tetrahydroberberine Suppresses Autophagy and Mitigates Doxorubicin‐Induced Ferroptosis in Hepatic Cells via cAMP ‐Epac1 Activation. Phytotherapy Research. 2026. doi:10.1002/ptr.70500
BibTeX
@article{Teng2026,
author = {Teng, Cheng and Chen, Mo and Zhao, Ying and Hu, Song and Kong, Linghui and Huang, Yan and Cai, Shunv and Zhu, Xiaoyan and Wang, Pengxiang and Xu, Pingbo},
title = {Tetrahydroberberine Suppresses Autophagy and Mitigates Doxorubicin‐Induced Ferroptosis in Hepatic Cells via cAMP ‐Epac1 Activation},
journal = {Phytotherapy Research},
year = {2026},
doi = {10.1002/ptr.70500}
}
EUVIMED